EHA 2020 | R/R DLBCL: impact of allo-HSCT conditioning on patient survival
Nilanjan Ghosh
Nilanjan Ghosh MD, PhD, of Levine Cancer Institute, Charlotte, NC, explores the impact of conditioning prior to allogeneic hematopoietic stem cell transplants (allo-HSCT) on survival for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
5:56 Detection of ctDNA in patients with MCL and CLL
Constantine Tam
6:23 Molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
Jessica Okosun
8:14 CART19-BE-01: ARI-0001 in CD19+ malignancies
ValentÃn Ortiz-Maldonado
2:59 CD5 and CD7 directed CAR T-cells for pediatric T-cell malignancies
Maksim Mamonkin
4:43 Waldenstrom's macroglobulinemia in the era of immunotherapy
Morie Gertz
